Columvi 2.5 mg/2.5 mL (1 mg/mL) injection Images

Generic Name: glofitamab

This medication has been identified as Columvi 2.5 mg/2.5 mL (1 mg/mL) injection. It is supplied by Genentech, Inc.

Columvi is used in the treatment of Diffuse Large B-Cell Lymphoma and belongs to the drug class bispecific T-cell engagers (BiTE). Columvi 2.5 mg/2.5 mL (1 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Columvi

Generic Name

glofitamab

Strength

2.5 mg/2.5 mL (1 mg/mL) injection

Availability

Prescription only

Drug Class

Bispecific T-cell engagers (BiTE)

CSA Schedule

Not a controlled drug

Labeler / Supplier

Genentech, Inc.

National Drug Code (NDC)

50242-0125

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer